EconomicChina·4 Nov 2026
Ping An Biomedical Enters Patent Purchase Agreement with Future Biotechnology Group
AI-summarized · Neutrality-checked
On November 4, 2026, Hong Kong-based Ping An Biomedical Co., Ltd. entered into a definitive agreement to acquire three oncology-related medical technology patents from Future Biotechnology Group Co., Limited for $2.3 million. This purchase followed a letter of intent signed by the companies on October 22, 2026. The acquisition aims to establish a core…
Loading full story…
Sources and context
Business Insider Markets
Digital newsroomCompany ownedUnited StatesStandards not yet verified
Source-level context, not a score for this article. Methodology and evidence · Report outdated information
Know where. Know why.